Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.

BACKGROUND AND PURPOSE Therapy of acute ischemic stroke can only be effective as long as neurons are viable and tissue is not infarcted. Since gamma-aminobutyric acid receptors are abundant in the cortex and sensitive to ischemic damage, specific radioligands to their subunits, the central benzodiazepine receptors (BZR), may be useful as indicators of neuronal integrity and as markers of irreversible damage. To test this hypothesis we studied the binding of the BZR ligand [11C]flumazenil (FMZ) early after ischemic stroke in comparison to the extent of final infarcts and hypometabolic cortical areas. METHODS In 10 patients cerebral blood flow, cerebral metabolic rate for oxygen (CMRO2), oxygen extraction fraction (OEF), and FMZ binding were studied by positron emission tomography 3.5 to 16 hours after onset of their first hemispheric stroke. Early changes in flow, oxygen metabolism, and FMZ binding were compared with permanent disturbances in glucose metabolism, and the size of the final infarcts was determined on MRI or CT 12 to 22 days after the stroke. RESULTS In all patients except one cerebral blood flow was disturbed, with marked decreases in eight and a hyperperfusion in one patient corresponding to the location of neurological deficits. In these areas CMRO2 was also reduced but to a variable degree, inducing highly variable OEF. Areas with markedly decreased CMRO2 (<60 micromol/100 g per minute) corresponded to regions with decreased FMZ binding (<4.0 times the mean value in the white matter). In all patients the final cortical infarcts were visible on the early FMZ images. Infarcts could be discriminated from noninfarcted cortex by decreased FMZ binding despite a wide range of OEF. In finally hypometabolic cortex FMZ binding was initially decreased or normal, with OEF covering a wide range; this suggested neuronal loss and/or deactivation as the cause of metabolic disturbance. Additionally, a highly significant correlation was found between FMZ distribution within the first 2 minutes after injection and regional cerebral blood flow. CONCLUSIONS These results demonstrate that permanently and irreversibly damaged cortex can be detected by reduced FMZ binding early after stroke. Since FMZ distribution additionally images regional cerebral perfusion, BZR radioligands have a potential as clinically useful tracers in patients with acute ischemic stroke. The evidence of tissue damage furnished by these tracers might be of relevance for the selection of individual therapeutic strategies.

[1]  A. Thiel,et al.  Ischaemic brain tissue salvaged from infarction with alteplase , 1997, The Lancet.

[2]  K Ohta,et al.  Repeat Positron Emission Tomographic Studies in Transient Middle Cerebral Artery Occlusion in Cats: Residual Perfusion and Efficacy of Postischemic Reperfusion , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  M. Fujita,et al.  Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  J S Duncan,et al.  Imaging and epilepsy. , 1997, Brain : a journal of neurology.

[5]  N. Lassen,et al.  Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. , 1997, Stroke.

[6]  L. Wilkins Practice Advisory , 1996, Neurology.

[7]  Reduction of 123I‐iomazenil uptake in haemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease , 1996, Nuclear medicine communications.

[8]  Fausto Viader,et al.  Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra , 1996, Annals of neurology.

[9]  A. Alexandrov,et al.  Brain SPECT and thrombolysis in acute ischemic stroke: time for a clinical trial. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  G. Donnan,et al.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[11]  C. Weiller,et al.  Ischemic stroke and incomplete infarction. , 1996, Stroke.

[12]  Uwe Pietrzyk,et al.  Eine Methode zur oberflächenbezogenen Quantifizierung funktioneller Daten am Beispiel des menschlichen Kortex , 1996, Bildverarbeitung für die Medizin.

[13]  I. Kanno,et al.  Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  J. Baron,et al.  Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. , 1995, Stroke.

[15]  C. Pozzilli,et al.  Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. , 1995, Archives of neurology.

[16]  J. Garcìa,et al.  Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. , 1995, Stroke.

[17]  B. Siewert,et al.  Acute human stroke studied by whole brain echo planar diffusion‐weighted magnetic resonance imaging , 1995, Annals of neurology.

[18]  U Pietrzyk,et al.  An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[20]  L. Calandre,et al.  Diaschisis in stroke. , 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[21]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.

[22]  K. Herholz,et al.  Positron emission tomography imaging and the therapeutic window. , 1993, Stroke.

[23]  Jean-Claude Baron,et al.  In Vivo Mapping of Brain Benzodiazepine Receptor Changes by Positron Emission Tomography After Focal Ischemia in the Anesthetized Baboon , 1993, Stroke.

[24]  J. Grotta,et al.  Value of Single‐Photon Emission‐Computed Tomography in Acute Stroke Therapeutic Trials , 1993, Stroke.

[25]  J. Baron,et al.  Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.

[26]  K Wienhard,et al.  Progressive Derangement of Periinfarct Viable Tissue in Ischemic Stroke , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  R. D. Schwartz,et al.  Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[28]  R. Koeppe,et al.  Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.

[29]  D E Kuhl,et al.  Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[30]  M. Limburg,et al.  Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF‐SPECT , 1991, Acta neurologica Scandinavica.

[31]  J. Mcculloch,et al.  Alterations in the N-Methyl-D-Aspartate Receptor Complex following Focal Cerebral Ischemia , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  Alan C. Evans,et al.  The Effect of Nimodipine on the Evolution of Human Cerebral Infarction Studied by PET , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  C. Bohm,et al.  Automated blood sampling systems for positron emission tomography , 1988 .

[34]  C. Cotman,et al.  Excitatory amino acid receptors and ischemic brain damage in the rat , 1987, Neuroscience Letters.

[35]  I. Martin The Benzodiazepine Receptor , 1986 .

[36]  M. Raichle,et al.  Cerebral Blood Flow and Cerebral Metabolic Rate of Oxygen Requirements for Cerebral Function and Viability in Humans , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  K Wienhard,et al.  Estimation of Local Cerebral Glucose Utilization by Positron Emission Tomography of [18F]2-Fluoro-2-Deoxy-D-Glucose: A Critical Appraisal of Optimization Procedures , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  C. Braestrup,et al.  Benzodiazepine receptors. , 1985, Clinical neuropharmacology.

[39]  Y. Koda,et al.  Therapeutic trials , 1984, Brain and Development.

[40]  R. Naquet,et al.  Central type benzodiazepine binding sites: A positron emission tomography study in the baboon's brain , 1984, Neuroscience Letters.

[41]  J. Baron,et al.  Journal of Cerebral Blood Flow and Metabolism Local Interrelationships of Cerebral Oxygen Consumption and Glucose Utilization in Normal Subjects and in Ischemic Stroke Patients: a Positron Tomography Study , 2022 .

[42]  M. Mintun,et al.  Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  K. Krnjević Neurotransmitters in Cerebral Cortex , 1984 .

[44]  Alan Peters,et al.  Functional properties of cortical cells , 1984 .

[45]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  T Jones,et al.  Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. , 1983, Brain : a journal of neurology.

[47]  W. Heiss,et al.  Flow and neuronal density in tissue surrounding chronic infarction. , 1983, Stroke.

[48]  N. Lassen Incomplete cerebral infarction‐‐focal incomplete ischemic tissue necrosis not leading to emollision. , 1982, Stroke.

[49]  B. Siesjö,et al.  Thresholds in cerebral ischemia - the ischemic penumbra. , 1981, Stroke.

[50]  D Comar,et al.  Reversal of Focal "Misery‐Perfusion Syndrome" By Extra‐Intracranial Arterial Bypass in Hemodynamic Cerebral Ischemia: A Case Study with 15O Positron Emission Tomography , 1981, Stroke.

[51]  A. Alavi,et al.  The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane , 1979, Circulation research.